Results 261 to 270 of about 179,601 (373)

Guideline for the Management Pathway and Quality Control of Breast Cancer Prevention and Treatment in China's Counties

Cancer Innovation, Volume 4, Issue 3, June 2025.
County hospitals bear the primary responsibility for health education, screening, primary diagnosis and treatment, maintenance treatment, management of adverse reactions to antitumor drugs, patient follow‐up, recurrence monitoring, rehabilitation guidance, and two‐way referrals for breast cancer.
Breast Cancer Expert Committee of National Cancer Quality Control Center, Cancer Prevention and Treatment Committee of Healthy China Research Center   +1 more
wiley   +1 more source

Corrigendum to Incoherence in the Brain Death Guideline Regarding Brain Blood Flow Testing: Lessons from the Much-Publicized Case of Zack Dunlap. [PDF]

Linacre Q
europepmc   +1 more source

Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy. [PDF]

Cancers (Basel)
Bogdanovic B, Hugonnet F, Montemagno C.
europepmc   +1 more source

Relationship Between Best Tumor Shrinkage and Progression‐Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [177Lu]Lu‐DOTA‐TATE: Ad Hoc Analysis of the Phase III NETTER‐1 Trial

Cancer Medicine, Volume 14, Issue 9, May 2025.
We analyzed data from the phase III NETTER‐1 study of 177Lu‑DOTATATE for patients with advanced midgut neuroendocrine tumors to explore whether tumor shrinkage is associated with durable efficacy. Although patients receiving 177Lu‑DOTATATE had a progression‐free survival (PFS) benefit, no obvious association between best tumor shrinkage and PFS or ...
Marianne Pavel, Martyn E. Caplin, Philippe Ruszniewski, Marianna Hertelendi, Eric P. Krenning, Jonathan R. Strosberg, on behalf of the NETTER‐1 Study Group   +6 more
wiley   +1 more source

SPECT/CT and triple-phase bone scan: A valuable diagnostic approach for identifying indications for secondary patellar resurfacing in patients with unexplained anterior knee pain post-TKA. [PDF]

Arthroplasty
Wu C, Wang H, Chen Z, Zhang J, Liu Z, Feng J, Jiang X, He C.   +7 more
europepmc   +1 more source

Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2021–2022

Mass Spectrometry Reviews, Volume 44, Issue 3, Page 213-453, May/June 2025.
Abstract The use of matrix‐assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this review is the 12th update of the original article published in 1999 and brings coverage of the literature to the end of 2022.
David J. Harvey
wiley   +1 more source

An ACTH-Producing Neuroendocrine Tumor: Clinical Course of Multidisciplinary Therapy Including Peptide Receptor Radionuclide Therapy - A Case Report. [PDF]

Case Rep Oncol
Koizumi T, Sato A, Kitajima K, Yamazaki M, Kanazawa S, Notake T, Sato Y, Kobayashi S, Iwaya M, Umeda T, Komatsu M.   +10 more
europepmc   +1 more source

Response of left ventricular volume to exercise in man assessed by radionuclide equilibrium angiography.

, 1979
Robert A. Slutsky, Joel S. Karliner, Donald R. Ricci, Gerhard Schüler, Matthias Pfisterer, Kirk E. Peterson, William L. Ashburn   +6 more
openalex   +1 more source

The Third Pillar of Precision Medicine — Precision Delivery

MedComm, Volume 6, Issue 5, May 2025.
For Precision Medicine to reach its full potential, a third pillar called Precision Delivery is starting to evolve to complement the existing two pillars of Precision Diagnosis and Precision Therapy. Precision Delivery will help ensure the right therapy for the right disease will be able to reach the right location at the right time .
Avnesh S. Thakor
wiley   +1 more source

Solvent extraction of Ac-225 in nano-layer coated, solvent resistant PDMS microfluidic chips. [PDF]

Sci Rep
Trapp S, Santoso A, Hounat Y, Paulssen E, van Ommen JR, van Steijn V, de Kruijff RM.   +6 more
europepmc   +1 more source